1. Home
  2. YEXT vs OABI Comparison

YEXT vs OABI Comparison

Compare YEXT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

N/A

Current Price

$7.72

Market Cap

644.4M

Sector

Technology

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

SELL

Current Price

$4.90

Market Cap

773.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
YEXT
OABI
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.4M
773.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
YEXT
OABI
Price
$7.72
$4.90
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
697.1K
★ 1.5M
Earning Date
12-07-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 131.82
6.56
EPS
★ 0.15
N/A
Revenue
★ $170,201,000.00
$18,666,000.00
Revenue This Year
N/A
$94.10
Revenue Next Year
$1.04
$30.33
P/E Ratio
$51.10
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.27
$1.35
52 Week High
$9.03
$5.45

Technical Indicators

Market Signals
Indicator
YEXT
OABI
Relative Strength Index (RSI) 62.47 49.23
Support Level $7.05 $4.43
Resistance Level $7.96 $5.34
Average True Range (ATR) 0.30 0.36
MACD -0.01 -0.04
Stochastic Oscillator 62.81 48.64

Price Performance

Historical Comparison
YEXT
OABI

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: